The Readout Loud

336: Pharma's big patent cliff, more obesity fundraising, and a failed ALS study

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

We chat about how pharmaceutical companies are navigating a looming patent cliff. We also talk about yet another obesity startup and a failed study from Google’s secretive anti-aging company Calico.

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file